Ligand Pharmaceuticals
LGND
#4112
Rank
S$2.74 B
Marketcap
$142.12
Share price
-0.44%
Change (1 day)
48.60%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): $2.08

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $2.06. In 2022 the company made an earnings per share (EPS) of -$2.60 a decrease over its 2021 EPS that were of $4.55.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.08-179.78%
2022-$2.60-157.23%
2021$4.55-2571.43%
2020-$0.18-100.46%
2019$40.26353.48%
2018$8.881025%
2017$0.79-700%
2016-$0.13-100.87%
2015$15.201859.32%
2014$0.785.36%
2013$0.748.0704505322479E+18%
2012$0.0000000000-100%
2011$0.64-194.23%
2010-$0.68548.38%
2009-$0.11-98.7%
2008-$8.13-136.52%
2007$22.25-787.8%
2006-$3.24-14.58%
2005-$3.79-21.31%
2004-$4.81-55.15%
2003-$10.7381.33%
2002-$5.922.74%
2001-$5.76-45.93%
2000-$10.65-14.56%
1999-$12.47-45.52%
1998-$22.88-3.97%
1997-$23.83132.31%
1996-$10.26

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$18.61 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.47-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.60 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
$2.40 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.45 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.14 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.22 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.73 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.52 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA